| 1 | Vlaicu, R., Niculescu, F., Rus, H ., and Cristea, A.: Immunoglobulins and complement fraction deposits in the atherosclerotic plaque of human aorta. IXth World Congress of Cardiology, Moscow, 1982. |
| 2 | Rus, H.G ., Niculescu, F., Cristea, A., and Vlaicu, R.: Complement components and immunoglobulins in human aortic atherosclerotic tissue. Vth International Congress of Immunology, Kyoto, 1983. |
| 3 | Niculescu, F., Rus, H.G ., Cristea, A., and Vlaicu, R.: Binding of C1 q , C3c, C4, IgG to human endothelium. Vth International Congress of Immunology, Kyoto, 1983. |
| 4 | Niculescu, F., Rus, H.G ., Cristea, A., and Vlaicu, R.: Localization of the membrane attack complex in the human aortic atherosclerotic wall. Vth European Immunology Meeting, Interlaken, 1984. |
| 5 | Vlaicu, R., Rus, H.G. , Niculescu, F., and Cristea, A.: Immune related proteins as components of the human aortic atherosclerotic intima. IXth European Congress of Cardiology, Düsseldorf, 1984. Eur. Heart. J. 5: 218, 1984. |
| 6 | Vlaicu, R., Cristea, A., Rus, H.G. , and Niculescu, F.: Characterization of the immune complexes in cardiac diseases. IXth European Congress of Cardiology, Düsseldorf, 1984. Eur. Heart. J. 5: 114, 1984. |
| 7 | Niculescu, F., Rus, H.G ., Constantinescu, E., Cristea, A., and Vlaicu, R.: Immunohistochemical localization of the terminal C5b-9 complement complexes in human fibrous plaques. IVth US-Romanian Workshop on Biomedical Research "Cellular and Molecular Events in Atherogenesis", Bucharest, 1985. Arteriosclerosis, 6: 244, 1986. |
| 8 | Vlaicu, R., Cristea, A., Bedeleanu, D., Rus, H.G ., and Niculescu, F.: Cardiospecificity of circulating immune complexes in heart disease. Xth World Congress of Cardiology, Washington, DC., 1986. |
| 9 | Niculescu, F.I., Rus, H.G., Cristea, A., and Vlaicu, R.: C5b-9, S-protein and C3d in human atherosclerotic coronaries and in myocardial areas with infraction. Xth World Congress of Cardiology, Washington, DC., 1986. |
| 10 | Rus, H.G. , Niculescu, F.I., Cristea, A., and Vlaicu, R.: Localization of the terminal C5b-9 complement complex in human atherosclerotic wall. Xth World Congress of Cardiology, Washington, DC., 1986. |
| 11 | Rus, H.G. , Niculescu, F., Cristea, A., and Vlaicu, R.: C5b-9 neoantigens in human atherosclerotic wall. VIth International Congress of Immunology, Toronto, 1986. |
| 12 | Niculescu, F., Rus, H.G. , Cristea, A., Nanulescu, M., and Vlaicu, R.: Complement activation in human tissues with sclerosis. VIth International Congress of Immunology, Toronto, 1986. |
| 13 | Niculescu, F., Rus, H.G. , and Vlaicu, R.: Cell recovery from complement attack in human arterial wall with atherosclerosis. XIth European Congress of Cardiology, Nice, 1988. Eur. Heart. J. 9: 87, 1988. |
| 14 | Rus, H.G ., Niculescu, F., and Vlaicu, R.: Localization of S-protein/vitronectin in human atherosclerosis. VIIth International Congress of Immunology, Berlin, 1989. |
| 15 | Niculescu, F., Rus, H.G ., Retegan, M., and Vlaicu, R.: C5b-9 deposition on malignant cells of breast cancer. VIIth International Congress of Immunology, Berlin, 1989. |
| 16 | Niculescu, F., Rus, H.G ., and Vlaicu, R.: Protective mechanisms against complement activation in the arterial wall with atherosclerosis. Vth US-Romanian Workshop on Biomedical Research, Prelesional Events in Atherogenesis, Bucharest, 1989. |
| 17 | Niculescu, F., Rus, H.G ., Retegan, M., and Vlaicu, R.: C5b-9 deposition on malignant cells of breast cancer. XIIIth International Complement Workshop, San Diego, 1989. Complement Inflamm. 6: 374, 1989. |
| 18 | Rus, H.G. , Niculescu, F., and Vlaicu, R.: The role of decay-accelerating factor (DAF) and CR1 (CD35) on the cells of human atherosclerotic wall. XIIIth International Complement Workshop, San Diego, 1989. Complement Inflamm. 6: 395, 1989. |
| 19 | Rus, H.G ., Niculescu, F., Retegan, M., and Vlaicu, R.: Decay-accelerating factor and CR1 in human breast cancer. IIIrd European Meeting on Complement in Human Disease. Bratislava, 1990. Complement Inflamm. 7: 140, 1990. |
| 20 | Niculescu, F., Rus, H.G. , and Vlaicu, R.: C5b-9 and TNF colocalization in human atherosclerotic wall. IIIrd European Meeting on Complement in Human Disease, Bratislava, 1990. Complement Inflamm. 7: 160, 1990. |
| 21 | Niculescu, F., Lang, T., Rus, H.G ., and Shin, M.L. G protein activation and diacylglycerol production in JY human B lymphoblastoid cell line treated with sublytic terminal complement complexes. XIVth International Complement Workshop, Cambridge, 1991, Complement Inflamm. 8: 199, 1991. |
| 22 | Rus, H.G., Kim, L., Niculescu, F., and Shin, M.L. Regulation of C3 expression in rat astrocytes by LPS, cytokines and virus. XIVth International Complement Workshop, Cambridge, 1991, Complement Inflamm. 8: 217, 1991. |
| 23 | Rus, H.G. , Niculescu, F., and Shin, M.L. Regulation of C3 expression in rat astrocytes by LPS, cytokines and virus. Gordon Research Conference on "Animal Cells and Viruses", Colby Sawyer College, New London, June 15-19, 1992. |
| 24 | Niculescu, F.I., Rus, H.G. , and Shin, M.L. Receptor-independent activation of GTP-binding, regulatory proteins by C5b-9. Gordon Research Conference on "Animal Cells and Viruses", Colby Sawyer College, New London, June 15-19, 1992. |
| 25 | Niculescu, F.I., Rus, H.G. , and Shin, M.L. Receptor-independent activation of GTP-binding, regulatory proteins by C5b-9. XV International Complement Workshop, Kyoto, 1993, Mol. Immunol. 30: 37, 1993. |
| 26 | Rus, H.G ., Niculescu, F.I., and Shin, M.L. Sublytic C5b-9 on oligodendrocytes reduces myelin protein mRNAs, induces oncogenes and cdc2 kinase activity. XV International Complement Workshop, Kyoto, 1993, Molec. Immunol. 30: 48, 1993. |
| 27 | Rus, H.G. , Niculescu, F.I., and Shin, M.L. C5b-9 regulates myelin protein, oncogenes and cdc2 kinase in oligodendrocytes. 25th Annual Meeting of American Society for Neurochemistry, Albuquerque, 1994. |
| 28 | Kim, Y.-U., Rus, H.G ., Wienecki, S., and Shin, M.L. Binding of a 35 KDA protein to TNF a mRNA AU-Rich domain is regulated by PKC in rat astrocytes. 25th Annual Meeting of American Society for Neurochemistry, Albuquerque, 1994. |
| 29 | Niculescu, F.I., Rus, H.G ., and Shin, M. L. Multiple signal pathways generated by assembly of terminal complement complexes (TCC) in the plasma membrane. Gordon Research Conference. Second Messengers and Protein Phosphorylation. Kimball Union Academy, Meriden, NH, 1994. |
| 30 | Rus, H.G ., Niculescu, F.I., and Shin, M.L. Reversal of terminal differentiation in oligodendrocytes by terminal complement complex. Gordon Research Conference. Second Messengers and Protein Phosphorylation. Kimball Union Academy, Meriden, NH, 1994. |
| 31 | Rus, H.G. , Niculescu, F.I., and Shin, M.L. Sublytic TCC on oligodendrocytes reduce myelin protein mRNAs, induces oncogenes and cyclin dependent kinases activity. 5th European Meeting on Complement in Human Diseases. Les Diableretes, Switzerland, Clin. Exp. Immunol.27, 2, 1994. |
| 32 | Niculescu, F., Rus, H.G ., and Shin, M.L. Multiple signaling pathways generated by assembly of TCC in the plasma membrane.5th European Meeting on Complement in Human Diseases. Les Diableretes, Switzerland, 1994. Clin. Exp. Immunol. 27, 2, 1994. |
| 33 | Rus, H.G ., Niculescu, F., and Shin, M.L. Effects of complement activation on cell cycle in oligodendrocytes: Progression from G1 to S-phase is c-jun dependent. 9th International Congress of Immunology, San Francisco, CA, 1995. |
| 34 | Niculescu, F., Rus, H.G ., and Shin, M.L. Raf-1/MapK activation introduced assembly of terminal complement complexes (TCC) . 9th International Congress of Immunology, San Francisco, CA 1995. |
| 35 | Rus, H.G ., Niculescu, F., and Shin, M.L. Effects of complement activation on cell cycle in oligodendrocytes: Progression from G1 to S-phase is c-jun dependent. FASEB Summer Conference "Protein Kinases and Protein Phosphorylation, Copper Mt., CO, July 16-21, 1995. |
| 36 | Niculescu, F., Rus, H.G. , and Shin, M.L. Raf-1/MapK activation introduced assembly of terminal complement complexes (TCC). FASEB Summer Conference "Protein Kinases and Protein Phosphorylation, Copper Mt., CO, July 16-21, 1995. |
| 37 | Rus, H.G ., Niculescu, F., and Shin, M.L. Sublytic complement attack regulate cell cycle in oligodendrocytes: The S-phase induction is dependent on c-jun activation. 27th ASN Meeting, Philadelphia, PA, March 2-6, 1996, J. Neurochem., 66: Suppl. 1, 589, 1996. |
| 38 | Niculescu, F., Rus, H.G ., and Shin, M.L. Assembly of terminal complement complexes induces activation of both ERK1 and JNK1 in B lymphocytes. 16th International Complement Workshop, Boston, MA, June 16-21, 1996, Mol. Immunol., 33: 82, 1996. |
| 39 | Rus, H.G ., Niculescu, F., and Shin, M.L. Sublytic assembly of terminal complement complexes on oligodendrocytes induces cell cycle and reduces apoptotic cell death. 16th International Complement Workshop, Boston, MA, June 16-21, 1996, Mol. Immunol., 33: 82, 1996. |
| 40 | Niculescu, F., Rus, H.G ., and Shin, M.L. Assembly of terminal complement complexes induces activation of both ERK1 and JNK1 in B lymphocytes. FASEB Research Conference on Receptor and Signal Transduction. Copper Mountain, CO, July 7-12, 1996. |
| 41 | Rus, H.G ., Niculescu, F., and Shin, M.L. Sublytic assembly of terminal complement complexes on oligodendrocytes induces cell cycle and reduces apoptotic cell death. FASEB Research Conference on Receptor and Signal Transduction. Copper Mountain, CO, July 7-12, 1996. |
| 42 | Niculescu, F., Rus, H.G ., and Shin, M.L. Activation of MAPK pathway by sublytic terminal complement complexes is G-protein dependent. 6th European Meeting on Complement in Human Disease. Innsbruck, Austria, March 12-15, 1997. Exp. Clin. Immunogenet., 14: 34, 1997. |
| 43 | Rus, H.G ., Niculescu, F., and Shin, M.L. Sublytic complement activation induces cell cycle and reduces apoptotic cell death in oligodendrocytes. 6th European Meeting on Complement in Human Disease. Innsbruck, Austria, March 12-15, 1997. Exp. Clin. Immunogenet., 14: 85, 1997. |
| 44 | Niculescu, F., Badea, T., and Rus, H .: Sublytic C5b-9 complexes induce proliferation of human aortic smooth muscle cells. Experimental Biology , San Francisco, April 18-22,1998, FASEB J, 12(4): A290, 1998. |
| 45 | Badea T., Niculescu, F., Shin M.L., and Rus, H.: Cloning of new genes induced by complement activation in OLG. Experimental Biology, San Francisco, April 18-22,1998, FASEB J, 12(4): A290, 1998. |
| 46 | Badea T., Niculescu, F., Shin M.L., and Rus, H. : Cloning of new genes induced by complement activation in OLG. Fifth International Congress of Neuroimmunology,Montreal, August 23-27 ,1998, J. Neuroimmunol 90:31 A158, 1998. |
| 47 | Dashiell SM., Rus, H , and Koski C.L.:The membrane attack complex of complement(C5b-9) induces proliferation and rescue from apoptosis of Schwann cells. Fifth International Congress of Neuroimmunology, Montreal, August 23-27 ,1998, J. Neuroimmunol 90:31 A158, 1998. |
| 48 | Olinic D., Cristea A., Stoia M., Marian I., Olteanu A., Rus H. , Niculescu F.N., Cucuianu M., and Olinic N.: Autoantibodies against oxidized LDL in patients with dyslipidemia and acute coronary syndomes. XXth Congress of the European Society of Cardiology, August 22-26, 1998, Vienna, Austria, European Heart J. 19, 44, P454, 1998. |
| 49 | Dashiell SM., Rus, H , and Koski C.L.: The membrane attack complex of complement(C5b-9) induces proliferation and rescue from apoptosis of Schwann cells. XVII International Complement Workshop, Rhodes, Greece, October 11-16, 1998, Molecular Immunology, 35(6-7): A133, 1998 |
| 50 | Badea T., Niculescu, F., Rus, H. , and Shin M.L.: Sublytic C5b-9 induces transcription of c-fos gene in myotubes and SRF binding to SRE/TCF sites. XVII International Complement Workshop, Rhodes, Greece, October 11-16, 1998, Molecular Immunology, 35: A275, 1998. |
| 51 | Badea, T., Niculescu, F., Shin, M.L., and Rus, H .: Molecular cloning of RGC-32, a novel gene induced by complement activation in oligodendrocyte. XVII International Complement Workshop, Rhodes, Greece, October 11-16, 1998, Molecular Immunology, 35: A276, 1998. |
| 52 | Niculescu, F., Badea, T., and Rus, H .: Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells. XVII International Complement Workshop, Rhodes, Greece, October 11-16, 1998, Molecular Immunology, 35: A277, 1998. |
| 53 | Rus, H.G ., Soane, L., Niculescu, F., and Shin, M.L.: Oligodendrocyte protection by sublytic C5b-9 from apoptotic cell death. XVII International Complement Workshop, Rhodes, Greece, October 11-16, 1998, Molecular Immunology, 35: A278, 1998. |
| 54 | Niculescu, F., Soane, L., Badea, T.C., Shin, M.L., and Rus, H .: Activation of Janus kinase 1 and STAT3 by sublytic C5b-9 in human aortic endothelial cells. Complement Biology, Experimental Biology, April 17-21, 1999, Washington, DC, A243.2, 1999. |
| 55 | Badea, T.C., Niculescu, F., Soane, L., Shin, M.L., and Rus, H .: Complement induced gene RGC-32 is a cdc2 binding protein. Complement Biology, Experimental Biology, FASEB J., 13: April 17-21, 1999, Washington, DC., A243.3, 1999. |
| 56 | Soane, L., Rus, H. , Niculescu, F., and Shin, M.L.: Oligodendrocyte protection by sublytic C5b-9 from apoptotic cell dath. Complement Biology, Experimental Biology, FASEB J., 13: April 17-21, 1999, Washington, DC., A243.4, 1999. |
| 57 | Niculescu, F., Badea, T., and Rus, H .: Sublytic C5b-9 induces proliferation of human aortic smooth muscle cells, 7th European Meeting on Complement in Human Disease. June 17-20, 1999, Helsinki, Finland, Mol. Immunol., 36:A86, 1999. |
| 58 | Soane, L., Rus, H. , Niculescu, F., and Shin, M.L.: Sublytic C5b-9 protects oligodendrocytes from apoptotic cell death., 7th European Meeting on Complement in Human Disease. June 17-20, 1999, Helsinki, Finland, Mol. Immunol., 36: A86, 1999. |
| 59 | Soane, L., Cho, H., Niculescu, F., Rus, H. , and Shin, M.L.: Sublytic C5b-9 promotes oligodendrocytes survival through inhibition of mitochondrial pathway of apoptosis. Immunpharmacol., 2000,49:16. XVIII International Complement Workshop, Salt Lake City USA 23-27 July, 2000. |
| 60 | Niculescu, F.,Soane, L., Badea, T.,Shin ML, and Rus, H .: Activation of STAT3 by sublytic C5b-9 in human aortic endothelial cells induces cell cycle. Immunpharmacol., 2000,49:93. XVIII International Complement Workshop, Salt Lake City USA 23-27 July, 2000. |
| 61 | Badea, T.C., Niculescu, F., Soane, L., Shin, M.L., and Rus, H .: Molecular cloning and expression of human RGC-32, a novel gene induced by complement and involved in cdc2 activation. Immunpharmacol., 2000,49:93. XVIII International Complement Workshop, Salt Lake City USA 23-27 July, 2000. |
| 62 | Soane, L., Cho, H., Niculescu, F., Rus, H. , and Shin, M.L.: Sublytic C5b-9 promotes oligodendrocytes survival through inhibition of mitochondrial pathway of apoptosis. Experimental Biology Seattle, May 12-16, FASEB J., 14:A1117,2000. |
| 63 | Niculescu, F.,Soane, L., Badea, T.,Shin ML, and Rus, H .:Activation of STAT3 by sublytic C5b-9 in human aortic endothelial cells induces cell cycle. Experimental Biology, FASEB J., 14:A961 May 12-16, Seattle, 2000. |
| 64 | Badea, T.C., Niculescu, F., Soane, L., Shin, M.L., and Rus, H .: cdc2 activation is enhanced by RGC-32, a novel gene induced by C5b-9 and involved in cell cycle activation. Experimental Biology, FASEB J., 14: A957 May 12-16, Seattle, 2000. |
| 65 | Niculescu, F.I., Rus, H ., and Shin, M.L. B lymphocytes activation by terminal complement complexes through Ras and MAPK pathway is G protein dependent. American College of Rheumatology 64th Annual Scientific Meeting, Philadelphila, October 2000, Arthritis Rheum. 43: S377, 2000. |
| 66 | Niculescu, F., Nguyen, P., Rus, V., Rus, H . and Via C.S. Spontaneous activation of JNK-1 and PI-3 kinase can be induced in lupus-like chronic GVHD in the P->F1 model. American College of Rheumatology 64th Annual Scientific Meeting, Philadelphila, October 2000, Arthritis Rheum. 43: S239, 2000. |
| 67 | Soane, L., Rus, H. , Niculescu, F., and Shin, M.L.: Oligodendrocytes protection by sublytic C5b-9 from apoptotic cell death. J. Neurochem., 74, Suppl: S8, 31th American Society of Neurochemistry Meeting , Chicago , March 26-29, 2000 . |
| 68 | Rus, H , Hila, S., Fosbrink, M., Rus, V., Soane, L.., and Niculescu, F. Sublytic C5b-9 induce aortic endothelial cell proliferation. Role of phosphatidylinositol 3-kinase and p70 S6 kinase. 11 th International Congress of Immunology, Stockholm , Sweden , July 22-27, Scand. J. Immunol. 54, Suppl. 1, p.92 , 2001 |
| 69 | Rus, H , Hila, S., Fosbrink, M., Rus, Soane, L.., and Niculescu, F. Sublytic C5b-9 induce aortic endothelial cell proliferation. Role of phosphatidylinositol 3-kinase and p70 S6 kinase. Experimental Biology, March 31-April 4, Orlando , 2001,FASEB J., 15:A686. |
| 70 | Weerth, S., Rus, H.G . Shin, M., and Raine, C.S. The membrane attack complex in inflammation and demyelination in EAE. International Neuroimmunology Congress , Edinburgh , England , September, J. Neuroimmunol. 118, 21, 2001. |
| 71 | Niculescu, F., Hila, S., Fosbrink, M., Rus,V Soane, L.., and Rus, H . Sublytic C5b-9 induce aortic endothelial cell proliferation. Role of phosphatidylinositol 3-kinase and p70 S6 kinase. 8th European Meeting on Complement in Human Disease. Strasbourg , France , 2001, Molec. Immunol. 2001, 38, 113. |
| 72 | Soane, L., Niculescu, F., Rus, H. , and Shin, M.L.: Sublytic C5b-9 protects oligodendrocytes from apoptosis by reguating BAD and BCL-2 through phosphatidylinositol 3-kinase /AKT and ERK pathway. 8th European Meeting on Complement in Human Disease. Strasbourg , France , 2001, Molec. Immunol. 2001, 38, 123. |
| 73 | H. Rus , Badea, T.C., Niculescu, F., Soane, M. Fosbrink, S. Hila, V. Rus, L., Shin, M.L., and F. Niculescu.: C5b-9 induced RGC-32 increases cdc2 kinase activity and activate cell cycle. Experimental Biology, April 20-24, New Orleans , FASEB J., 16: A957, 2002. |
| 74 | Weerth, S., Rus, H.G. Shin, M., and Raine, C.S. Effect of complement C5 on gliosis and remyelination in experimental autoimmune encephalomyelitis. American Association of Neuropathologists Meeting , Denver , June, J. Neuropathol. Exp. Neurol. 118, 444, 2002. |
| 75 | Badea, T.C., Niculescu, F., Soane, M. Fosbrink, S. Hila, V. Rus, L., Shin, M.L. and . H. Rus , : Cell proliferation induced by C5b-9 is mediated by RGC-32 activation of cdc2 kinase. XIX International Complement Workshop, Palermo , Italy , September 22-26, 2002 . Inter. Immunopharmacol., 2002,9:1270. |
| 76 | Niculescu, F., Hila, S., Fosbrink, M., Rus,V, Popescu T., Shustova V., Soane, L.., and Rus, H . Endothelial cell proliferation induced by sublytic C5b-9 require activation p70 S6 kinase through a mechanism involving the G-protein dependent activation of of phosphatidylinositol 3-kinase .XIX International Complement Workshop, Palermo, Italy, September 22-26, 2002. Inter. Immunopharmacol., 2002,9:1219. |
| 77 | Rus, H.G ., Weerth, S., Soane, L., Niculescu, F., Raine, C.S. and Shin, M. The effect of complement terminal complement complex on apoptosis gene expression in experimental autoimmune encephalomyelitis. XIX International Complement Workshop, Palermo , Italy , September 22-26, 2002 , Inter. Immunopharmacol., 2002,9:1248. |
| 78 | M.L. Shin., and H. Rus : Complement: Dual Role in injury and protection. ACTRIMS-ECTRIMS, September 18-21, 2002 , Baltimore , USA , Multiple Sclerosis, 2002, 8, Suppl. 1, pS13. |
| 79 | Niculescu, F., Nguyen, P., Niculescu T, Rus, H ., Rus, V. and Via C.S. Pathogenic T cells in murine lupus exhibit spontaneous signaling activity through phosphatidylinositol 3-kinase and MAP kinase pathways. American College of Rheumatology 66th Annual Scientific Meeting, New Orleans , October 24-29, 2002 , Arthritis Rheum. 46: S454, 2002. |
| 80 | Rus H ., Weerth, S., Soane, L., Niculescu T., Niculescu F., Rus, V., Raine, CS., Shin, M.L. Effects of membrane attack complex of complement on apoptosis in experimental autoimmune encephalomyelitis. Apoptosis 2003 Meeting , Luxembourg , January 29- February 1, 2003 . |
| 81 | Rus H ., Weerth, S., Niculescu T., Niculescu F., Rus, V., Raine, CS., Shin, M.L. Effects of membrane attack complex of complement on apoptosis in experimental autoimmune encephalomyelitis. Immunology 2003, May 6-10, Denver , FASEB J., 17: C109, 2003. |
| 82 | Fosbrink, M., Badea T., Shin, M.L., Rus H . Regulation of RGC-32 mRNA expression by terminal complement complex C5b-9 and growth factors. Immunology 2003, May 6-10, Denver , FASEB J., 17: C108, 2003 |
| 83 | Niculescu T., Weerth, S., Niculescu F., Rus, V., Raine, CS., Shin, M.L, Rus H ., Effects of membrane attack complex of complement on apoptosis in experimental autoimmune encephalomyelitis. Mol. Immunol. 2003, 40, 179. September, 9 th European Complement Workshop, September 6-9, 2003 , Trieste , Italy . |
| 84 | Calabresi, P., Rus, H ., Niculescu, T., Niculescu, F.,H. Knaus The voltage gated potassium channel Kv1.3 is expressed on inflammatory cells in multiple sclerosis brain tissue. ECTRIMS 2003, 19 th congress of the European Committee for treatement and Research of Multiple Sclerosis, Spetember 17-20, 2003, Milan, Italy,, Multiple Sclerosis, 2003, 9, supp. 1, S10. |
| 85 | Rus H ., Jensen T., Cudrici, C, Niculescu T.,Reed, J., Fosbrink, M., Niculescu F. C5b-9 terminal Complement Complex protects Oligodendrocytes from apoptosis by regulating FLIP. FASEB 2004, April 17-21, Washington , DC , FASEB J., 18: A1159, 2004. |
| 86 | Fosbrink, M., Niculescu, F., Hila, S., Soane, L., Niculescu, T., Zernetkina, V., Rus, V., Shin, M.L., Rus H . Multiple signaling pathways are required for C5b-9 induced endothelial cell proliferation. FASEB 2004, April 17-21, Washington , DC , FASEB J., 18: A1159, 2004. |
| 87 | Niculescu T,Weerth S, Niculescu F, Cudrici C, Rus V, Raine CS, Shin ML and H. Rus Effect of complement C5 on Fas system in experimental autoimmune encephalomyelitis.XXth International Complement Workshop 13-18 th June 2004 , Honolulu , Hawaii , Molecular Immunology41,issues 2-3,285,2004 |
| 88 | H. Rus The dual role of complement activation in autoimmune demyelination. EU Conference on Atherosclerosis, Diabetes and Immune disorders. Bucharest, Romania, September 9-12, 2004 |
| 89 | Niculescu T, Weerth S, Niculescu F, Cudrici C, Rus V, Raine CS, Shin ML and H. Rus Effect of complement C5 on apoptosis in experimental autoimmune encephalomyelitis. 7 th International Congress of Neuroimmunology, September 28-October 2, Venice, Italy, J. Neuroimmunology, 2004, 154, 200 |
| 90 | Cudrici, C., Summers, D., Jansen, T. Fosbrink, M,.and H Rus. C5b-9 protects oligodendrocytes from apoptosis by regulating BH3-only proapoptotic proteins. ExperimentaL Biology, 2005, April 2-6, San Diego, FASEB J, 2005, 19, 200. |
| 91 | Mullen, K.M., Rozycka, M., Hu, L., Rus, H., Graber, J., Pennington, M.W., Johns, D.C., Judge, S.I., Calabresi, P.A. Potassium Channels IR, Kv 1.5, and Kv 1.3 are expressed on human dendritic cells and have a functional role in maturation. FOCIS, 5th Annual Meeting, May 12-16, Boston, Clinical Immunology, 2005,115, S1-S2, S270. |
| 92 | Cudrici, C, F. Niculescu, P.A. Calabresi, Rus, H. Normal appearing gray matter in multiple sclerosis is associated with increased cellular infiltration, ECTRIMS, ACTRIMS 2005, September 28-October 1, 2005. Multiple Sclerosis 11, Suppl 1, pS42. |
| 93 | Cudrici,C, Niculescu,F. Jensen, T, Zafranskaia, E, Fosbrink, M Rus, V, Shin,M.L, Rus, H, C5b-9 dependent activation of PI-3K protects oligodendrocytes from apoptosis by inhibiting caspase-8 processing through upregulation of FLIP. 10th European Meeting on Complement in human diseases, Heidelberg, September 9-13, 2005. Mol. Immunol. 2006, 43, 136. |
| 94 | H. Rus, C. Cudrici, F. Niculescu, C5b-9 complement Complex in autoimmune demyelination: dual role in neuroinflammation and neuroprotection. 3rd Workshop on Complement Associated Diseases, animal models and therapeutics. June 5-10, 2005, Rhodes, Greece. |
| 95 | Fosbrink M., Cudrici C, Badea T, Rus V., Niculescu F., Rus H. Cell cycle activation nduced by sublytic C5b-9 is RGC-32 dependent, AAI , May 12-16,Boston, J. Immunol. 53.6 S77, 2006. |
| 96 | Cudrici C, Zafranskaia E,Weerth S., Chen H., Gherman A., Rus V., Raine C., Shin ML., Rus H., Effect of complement C5 on gene expression profile in Experimental Autoimmune Encephalomyelitis, AAI, May 12-16,Boston, J. immunol. 53.17 S79, 2006. |
| 97 | Cudrici, C, Zafranskaia E, F. Niculescu, K. Mullen, S. Judge, P.A. Calabresi, Rus, H. Dendritic cells are abundant in non-lesional gray matter in multiple sclerosis, ECTRIMS 2006, Madrid, September 27-30, 2006. Multiple Sclerosis 12, Suppl 1, pS223. |
| 98 | Fosbrink, M, Niculescu, F., Rus, V., Shin ML, and H Rus. C5b-9 induced Endothelial Cell Proliferation and migration is dependent on AKT inactivation of forkhead transcription factor FOXO1. XXith International Complement Workshop, 22-26th October 2006, Beijing, China, Mol Immunol 44, 170, 2007. |
| 99 | Cudrici C, Zafranskaia E, Weerth S., Chen H., Gherman A., Ito, T, Rus V., Raine C., Shin ML., Rus H. Complement C5 regulates insulin-like growth factors binding proteins in chronic Experimental Autoimmune Encephalomyelitis, AAI Meeting, May 18-22, Miami Beach. |
| 100 | C. Cudrici, T. Ito, E. Zafranskaia, S. Weerth, H.H. Chen, A. Gherman, K. Soloviova, V. Rus, C. S. Raine, H. Rus. Complement C5 regulates Insulin-like growth factors binding proteins in chronic experimental allergic encephalomyelitis. 13th International Congress of Immunology, Rio de Janiero Brazil, August 21-25, 2007. |
| 101 | C. Cudrici, T. Ito, E. Zafranskaia, S. Weerth, H.H. Chen, A. Gherman, K. Soloviova, V. Rus, C. S. Raine, H. Rus. Complement C5 regulates insulin-like growth factors binding proteins in chronic experimental allergic encephalomyelitis. 11th European Meeting on Complement in human diseases, Cardif, September 8-11, 2007. Mol. Immunol. 2007,44,3989. |
| 102 | C. Cudrici, T. Ito, E. Zafranskaia, S. Weerth, H.H. Chen, A. Gherman, K. Soloviova, V. Rus, C. S. Raine, H.Rus. Complement C5 protects against gliosis in chronic experimental allergic encephalomyelitis through regulation of insulin-like growth factors binding proteins. 3rd International Conference on Autoimmunity. October 7-12, 2007, Rhodes, Greece. |
| 103 | Vlaicu, S, Cudrici, C, A. Shamsuddin, V. Rus, P. Mircea, H. Rus. Overexpression of RGC-32 in benign and malignant colonic tissues, Colorectal Cancer Congress 2008, 24 - 26 February 2008; Berlin, Germany, Ann Oncol. 2008, 19, Suppl. 1, i31. |
| 104 | C. Cudrici, K. Soloviova, M. Rozycka, C. A. Tegla, S. I. V. Judge, H. Rus. Regulation of Kv1.3 expression by C5b-9 terminal complex in oligodendrocytes and their role cell cycle activation. Experimental Biology, 2008, April 5-9, San Diego. |
| 105 | C. Cudrici, C. Tegla, M. Rozycka, V. Rus, S. I. V. Judge, H. Rus. Regulation of C5b-9 induced cell cycle in oligodendrocytes by Kv1.3 potassium channels. XXII Complement International Workshop, Basel, September 28-October 2, 2008. |
| 106 | Cudrici, C, Tegla, CA, V. Rus, Rus, H. Imatinib mesylate reduced production of extracellular matrix and connective tissue factor in astrocytes, WCTRIMS 2008, Montreal, September 17-20, 2008. Multiple Sclerosis 14, Suppl 1, S242-243. |
| 107 | Ford C, Johnson K, Kachuck N, Linsey WJ, Lisak, R, Luzzio C, Myers, L, Panitch, H, Preiningerova, J, Pruitt, A, Rose, J, Rus, H., Wolinsky, J. Continuous long-term immunomodulatory therapy in relapsing-remitting multiple sclerosis: results from 15-year analysis of US prospective open-label study of glatiramer acetate. WCTRIMS 2008, Montreal, September 17-20, 2008. Multiple Sclerosis 14, Suppl 1, S41. |
| 108 | Tegla, C.A, . Cudrici, A. Singh, M. Rozycka, V. Rus, S. I. V. Judge, H. Rus. C5b-9 activated Kv 1.3 channel-sensitive Akt pathway mediate oligodendrocytes proliferation. AAI 2009, May 8-12, Seattle. J. Immunol. 2009, 182, 135.7 |
| 109 | Tegla, C A, Ito T, Cudrici, C and H Rus. C5b-9 inhibits myelin gene expression in oligodendrocyte progenitor cells. AAI 2009, May 8-12, Seattle. J. Immunol., 2009, 182, 134.68. |
| 110 | Vlaicu, S, Tegla, CA, Cudrici, C, Rus, V., Mircea, P., Rus H. RGC-32 regulates histone H2B acetylation in colon cancer cells Ann. Oncol., 20, 2009 Supplement 7 vii 34. 11th World Congress on Gastrointestinal Cancer 24-27 June, 2009: Barcelona, Spain. |
| 111 | Tegla, C A, Cudrici, C, Nguyen V, Vlaicu S, Costello K, Royal W, Bever C, Rus V, and H Rus. Clinical activity in relapsing-remitting multiple sclerosis is associated with a decrease in RGC-32 mRNA expression in peripheral blood. ECTRIMS 2009, Dusseldorf, Germany, September 9-12, 2009. Multiple Sclerosis 15, Suppl 1, S189. |
| 112 | Tegla, C A, Vlaicu, S, Cudrici, C, Fosbrink, M, Nguyen V, Azimzadeh, P, Rus V, Shamsuddin, V. Rus, H. RGC-32 regulates chromatin assembly in colon cancer. AAI 2010, May 8-12, Baltimore. J. Immunol. 2010, 184, 100.35. |
| 113 | Nguyen V, Tegla, C A, Luzina, I, Rus, H, Rus V, IL-21/IL-21R interactions on host B cells but not on donor cells CD4 cells are critical for the development of autoimmune features in chronic graft versus host disease. AAI 2010, May 8-12, Baltimore. J. Immunol. 2010, 184, 93.9. |
| 114 | C. Tegla, C. Cudrici, A. Singh, M. Rozycka, V. Rus, S. I. V. Judge, H. Rus. Voltage gated potassium Kv1.3 channel mediate C5b-9 induced oligodendrocyte proliferation . 14th International Congress of Immunology, Kobe, Japan, August 22-27, 2010. Int. Immunol. 22, Supp. 1, iv87, 2010. |
| 115 | C A. Tegla, C. Cudrici, S I. Vlaicu, A Khan, F Niculescu, V Rus, H Rus. C5b-9 regulates histone deacetylases and oligodendrocyte-specific gene expression. XXIII International Complement Workshop, New York, August 1-5, 2010. |
| 116 | C. A. Tegla, C. Cudrici, V. Nguyen, P. Azimzadeh, V. Rus, M. Andrian-Albescu, H. Rus. Abnormal Histone Modification Patterns in relapsing-remitting multiple sclerosis. ECTRIMS 2010: Gothenburg, Sweden • 13-16 October 2010, Multiple Sclerosis 2010, 16, Suppl. 10, S237. |
| 117 | C. Tegla, C. Cudrici, A. Singh, S. I. Vlaicu, V. Nguyen, V. Rus, H. Rus. Response gene to Complement-32 mediated TGF-beta induced production of extracellular matrix by astrocytes. AAI Meeting, 2011, May 13-17, San Francisco. CA. J. Immunol. , 2011, 186, 44.16 |
| 118 | Nguyen, V, Luzina, I, Chen, Q, Rus, H, VRus. IL-21/IL-21R interaction on both CD4 cells and B cells is required to promote autoimmune parameters in chronic graft versus host disease. AAI Meeting, 2011, May 13-17, San Francisco. CA., J Immunol 2011 186:44.10 |
| 119 | C. A. Tegla, C. Cudrici, V. Nguyen, P. Azimzadeh, S.I. Vlaicu, V. Rus, H. Rus. SIRT1 expression is decreased in patients with relapsing-remitting multiple sclerosis. ECTRIMS/ ACTRIMS 2011: Amsterdam, Netherlands • October 19-22, 2011, Multiple Sclerosis J, 2011, 17, Suppl. 10, S123. |
| 120 | Tegla, CA, Cudrici, C, A. Singh, Vlaicu, S, Nguyen, V, Rus, V, Rus, H. Response gene to Complement-32 is required for TGF-beta induced production of extracellular matrix by astrocytes. 43th ASN Meeting, Baltimore, March 03-07, 2012. |
| 121 | H. Rus: Cell cycle activation and migration induced by sublytic C5b-9 in endothelial cells is RGC-32 dependent. XVI International Symposium on Atherosclerosis 2012, March 25-29, 2012, Sydney, Australia. |
| 122 | C. A. Tegla, C.D. Cudrici, V. Nguyen, A. Khan, S. I. Vlaicu, V. Stewart, V. Rus, T. C. Badea, H. Rus. Enhanced cell cycle activation in response to stimulation in RGC-32-/- T lymphocytes . AAI Meeting, 2012, May 5-8, Boston, MA. |
| 123 | C. A. Tegla, C. Cudrici, V. Nguyen, P. Azimzadeh, S.I. Vlaicu, W. Royal III V. Rus, H. Rus. Dual role of RGC-32 in multiple sclerosis. ECTRIMS 2012 Lyon, France, October 10-13, Multiple Sclerosis J 2012, 18, Suppl. 4, 501. |
| 124 | Nguyen, V, Veizaga-Udaeta, D, Rus, H, Rus, V. CTL-Promoting effects of IL-21 results in B Cell elimination and disease improvement in a murine model of lupus. ACR Meeting, Washington DC, Arthritis Rheum 2012, 64, Suppl. 10, pp618 |
| 125 | C. A. Tegla, C. Cudrici, V. Nguyen, P. Azimzadeh, S.I. Vlaicu, W. Royal III C. Bever, V. Rus, H. Rus. RGC-32 as a biomarker of relapses in multiple sclerosis. 11th International Congress of Neuroimmunology, November 5-8, Boston, USA, J. Neuroimmunology, 2012, 252, 12, 22. |
| 126 | C. A. Tegla,C. Cudrici,V. Nguyen, J. Danoff, S. I. Vlaicu, V. Rus,T. C. Badea, H Rus Characterization of the in vivo function of RGC-32 in T-cells. AAI Meeting, 2013, May 3-7, Honolulu, HI, The Journal of Immunology, 2013, 190, 50.18 . |
| 127 | V Rus, V. Nguyen,C. A. Tegla, C. Chen, H Rus CTL-promoting effects of IL-21 counteract murine lupus and outweigh B cell stimulatory effects. AAI Meeting, 2013, May 3-7, Honolulu, HI, The Journal of Immunology, 2013, 190, 195.2. |
| 128 | Tegla, C., Cudrici, CD, Ito, T, V. Rus, H. Rus. Response gene to complement-32 mediates C5b-9 induced cell cycle activation and migration in endothelial cells. 15th International Congress of Immunology, August 22-27, 2013, Milan, Italy. |
| 129 | C.A. Tegla, C. Cudrici, J. Danoff, A. J. Sugarman, D. Boodhoo, V. Rus, H. Rus. RGC-32 regulates extracellular matrix expression in multiple sclerosis lesions. 29th ECTRIMS Congress; Copenhagen, Denmark, October 2-5, 2013. Multiple Sclerosis, 2013; 19: (S1) 74-558. |
| 130 | Tegla C., C. Cudrici, J. Danoff, A. J. Sugarman, D. Boodhoo, A. Martin,V. Rus, H. Rus. RGC-32 regulates extracellular matrix expression in multiple sclerosis lesions. 45th ASN Meeting, Long Beach, March 08-12, 2014. |
| 131 | Cosmin Tegla, Cornelia Cudrici, Dallas Boodhoo, Alvaro Martin, Jacob Danoff, Adam Sugarman, Violeta Rus, and Horea Rus. RGC-32 regulates TGF- β extracellular matrix expression in reactive astrocytes. J Immunol 2014 192:52.20 |
| 132 | Violeta Rus, Cosmin Tegla, Vinh Nguyen, Cornelia Cudrici, Tudor Badea, and Horea Rus. CD4 T Cell Differentiation Session RGC-32 is essential for TGF-β mediated Th17 cell differentiation J Immunol 2014 192:64.2 |
| 133 | C. A. Tegla, C. Cudrici, J. Danoff, A. Sugerman, D. Boodhoo, V. Rus, H. Rus. RGC-32 regulates extracellular expression in multiple sclerosis lesions. ACTRIMS/ECTRIMS 2014 Boston, September 10-13. |
| 134 | Vinh Nguyen, Cosmin Tegla, Cornelia Cudrici, Tudor Badea, Horea Rus, Violeta Rus. Lack of RGC-32 impairs Th17 differentiation and attenuates Lupus-like chronic graft versus host disease. American College of Rheumatology Meeting, November 14 - 19, 2014; Boston, MA. |
| 135 | H. Rus, C. Tegla, V. Nguyen, C. Cudrici, T. Badea, Violeta Rus. RGC-32 is essential for TGF-β mediated Th17 differentiation. XXV INTERNATIONAL COMPLEMENT WORKSHOP, September 14-18, Rio de Janeiro, Brazil. |
| 136 | C. A. Tegla, C. Cudrici, D. Boodhoo, A. Martin, A. Sugerman V. Rus, H. Rus. RGC-32 regulates TGF-β induced extracellular matrix expression in reactive astrocytes.. XII International Congress of Neuroimmunology, November 9-13, 2014; Mainz, Germany, |
| 137 | Horea Rus, Cosmin Tegla, Cornelia Cudrici, Vinh Nguyen, Adam Kruszewski, Amurgam Mekala, Violeta Rus, and Tudor Badea. RGC-32 regulates T lymphocyte cell cycle activation in a phosphatidylinositol 3- kinase and IL-2 -dependent manner. J Immunol 194:129.6, AAI 2015, May 8-12; New Orleans, LA |
| 138 | Violeta Rus, Vinh Nguyen, Tudor Badea, Cornelia Cudrici, Cosmin Tegla, Armugam Mekala, and Horea Rus. RGC-32 enhances suboptimal CD8 cytotoxic T cell effector function in acute graft versus host disease and promotes lupus-like disease in chronic graft versus host disease. J Immunol 194: 67.16, AAI 2015 May 8-12; New Orleans, LA. |
| 139 | Adam M. Kruszewski, Cosmin A. Tegla, Cornelia Cudrici, Vingh Nguyen, Gautam K. Rao, Walter Royal III, Christopher T. Bever Jr., Violeta Rus, Horea Rus. RGC-32, FasL, and SIRT1 as Potential Biomarkers of Relapse and Response to Treatment with Glatiramer Acetate in Multiple Sclerosis. InterJMSCare 17:1.29, 29th Annual Meeting of the Consortium of Multiple Sclerosis Centers, May 27-12, 2015; Indianapolis, Indiana. |
| 140 | Violeta Rus, Vinh Nguyen, Tudor Badea, Cornelia Cudrici, Cosmin Tegla, Armugam Mekala, and Horea Rus. RGC-32 enhances suboptimal CD8 cytotoxic T cell effector function in acute graft versus host disease and promotes lupus-like disease in chronic graft versus host disease. J Immunol 194:67.16, 11th International Congress on Systemic Lupus Erythematosus, September 2-6, 2015; Vienna, Austria. |
| 141 | A. Tatomir, C.A. Tegla, C.D. Cudrici, D. Boodhoo, A. Martin, A. Mekala, V.Rus, H. Rus. RGC-32 regulates TGF- β extracellular matrix expression in astrocytes. ECTRIMS, October 6-10, 2015; Barcelona, Spain. |
| 142 | H. Rus, A. Kruszewski, C. Cudrici, V. Nguyen, W. Royal, C. Bever, V. Rus. RGC-32 As a Potential Marker of Relapse and Response to Treatment with Glatiramer Acetate in Multiple Sclerosis. XXII World Congress of Neurology, October 31- November 5, 2015; Santiago, Chile. |
| 143 | V. Nguyen, A. Tatomir, A. Mekala, H. Rus, and V. Rus. Response Gene to Complement-32 Promotes Plasma Cell Differentiation and Enhances Lupus-like Chronic Graft Versus Host Disease. ACR/ARHP Annual Meeting November 6-11, 2015; San Francisco, CA. |
| 144 | Alexandru Tatomir, Cosmin A Tegla, Cornelia D Cudrici, Dallas Boodhoo, Alvaro Martin, Armugam Mekala, Violeta Rus, Tudor C Badea and Horea Rus. RGC-32 regulates TGF-β extracellular matrix production in multiple sclerosis. J. Immunol. 2016 vol.196 (1 Supplement) 133.2. , AAI 2016, May 13-17; Seattle, WA. |
| 145 | Violeta Rus, Vinh Nguyen, Alexandru Tatomir, Armugam Prasad Mekala, Horea G Rus. Response Gene to Complement-32 promotes Th17 cell differentiation through TGF-β dependent and independent mechanisms. . J. Immunol. 2016 vol.196 (1 Supplement) 189.7. , AAI 2016, May 13-17; Seattle, WA. |
| 146 | Hewes, D, A. Kruszewski,, Tatomir, A, Rus, H. Sirt1 as a potential marker of disease activity and response to therapy to treatment with glatiramer acetate. CMSC Meeting, 2016, June 1-4, National Harbor, MD. |
| 147 | A. Tatomir, D. Boodhoo, C. A. Tegla, C. Cudrici, S. Weerth, V. Rus, H. Rus. Complement C5 regulates TGF-β and Response Gene to Complement -32 expression in Experimental Autoimmune Encephalomyelitis. 16th International Congress of Immunology, August 21-67, 2016, Melbourne, Australia. |
| 148 | Alexandru Tatomir, Violeta Rus, Vinh Nguyen, Armugam Prasad Mekala, Horea G Rus. Response Gene to Complement-32 promotes Th17 cell differentiation through TGF-β dependent and independent mechanisms. ECTRIMS 2016, London, September 14-17, 2016 |
| 149 | A. Tatomir, V. Nguyen, C. Tegla, C. Cudrici, T. Badea, H. Rus, and V. Rus. Response Gene to Complement-32 Promotes Plasma Cell Differentiation and Enhances Lupus-like Chronic Graft Versus Host Disease. Lupus, 2016, 3 (Suupl 1) AI-05. Third Biannual Scientific Meeting of North and South American Lupus Community. Armonk, New York, USA, September 29 – October 1, 2016 |
| 150 | Daniel Hewes, Alexandru Tatomir, Adam M Kruszewski, Jonathan Criello, Gautam K Rao, Walter Royal III, Christopher T Bever, Horea Rus. SIRT1 as a potential marker of disease activity and response to treatment with Glatiramer Acetate in multiple sclerosis. Multiple Sclerosis Journal, 2017, 23 (suppl. 1) P008. ACTRIMS Meeting, February 23-25, 2017, Orlando, FL. |
| 151 | Alexandru Tatomir, Violeta Rus, Vinh Nguyen, Dallas Boodhoo, Armugam P Mekala, Cornelia D Cudrici, Tudor C Badea, Horea Rus. RGC-32 promotes Th17 cell differentiation and enhances experimental autoimmune encephalomyelitis. Multiple Sclerosis Journal, 2017, 23 (suppl. 1) P159. ACTRIMS Meeting, February 23-25, 2017, Orlando, FL. |
| 152 | H. Rus , A. Tatomir , V. Nguyen, C. Cudrici, T. Badea, V. Rus. Response Gene to Complement-32 Promotes Plasma Cell Differentiation and Enhances Lupus-like Chronic Graft Versus Host Disease. Lupus 2017, March 26-29, Melbourne, Australia. |
| 153 | Alexandru Tatomir, Gautam Rao, Dallas Boodhoo, Jonathan Ciriello, Violeta Rus and Horea Rus Role of SIRT1 in C5b-9 mediated oligodendrocyte cell cycle activation J Immunol May 1, 2017, 198 (1 Supplement) 55.21; AAI 2017, May 12-16; Washington, DC. |
| 154 | Violeta Rus, Vinh Nguyen, Alexandru Tatomir, Armugam Prasad Mekala, Dallas Boodhoo and Horea G Rus RGC-32 enhances experimental autoimmune encephalomyelitis by promoting Il-17 and GM-CSF production. J Immunol, 2017, 198 (1 Supplement) 219.16; AAI 2017, May 12-16; Washington, DC. |
| 155 | Gautam Rao, Alexandru Tatomir, Gautam Rao, Dallas Boodhoo, Jonathan Ciriello, Violeta Rus and Horea Rus Role of SIRT1 in C5b-9 mediated oligodendrocyte cell cycle activation. Inter J MS Care 19:Suppl 1.36, CMSC Meeting, 2017, May 24-27, New Orleans, LA. |
| 156 | Alexandru Tatomir, Gautam Rao, Dallas Boodhoo, Jonathan Ciriello, Violeta Rus and Horea Rus Histone deacetylase SIRT1 mediates C5b-9 -induced cell cycle in oligodendrocyte. 7th Joint ACTRIMS-ECTRIMS Meeting, Paris, October 25-28, 2017. |
RusLab Home Page
subglobal1 link | subglobal1 link | subglobal1 link | subglobal1 link | subglobal1 link | subglobal1 link | subglobal1 link
subglobal2 link | subglobal2 link | subglobal2 link | subglobal2 link | subglobal2 link | subglobal2 link | subglobal2 link
subglobal3 link | subglobal3 link | subglobal3 link | subglobal3 link | subglobal3 link | subglobal3 link | subglobal3 link
subglobal4 link | subglobal4 link | subglobal4 link | subglobal4 link | subglobal4 link | subglobal4 link | subglobal4 link
subglobal5 link | subglobal5 link | subglobal5 link | subglobal5 link | subglobal5 link | subglobal5 link | subglobal5 link
subglobal6 link | subglobal6 link | subglobal6 link | subglobal6 link | subglobal6 link | subglobal6 link | subglobal6 link